Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Hum Exp Toxicol ; 38(4): 434-445, 2019 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-30545268

RESUMO

Ochratoxin A (OTA) and citrinin (CTN) commonly coexist in grains. Aiming to evaluate oxidative stress in OTA + CTN toxicity, male Wistar rats were orally treated with two doses of OTA (0.125 and 0.250 mg kg-1 of body weight (b.w.)), CTN (2 mg kg-1 of b.w.) and resveratrol (RSV; 20 mg kg-1 of b.w.) and combined daily during 3 weeks. Protein carbonyl concentrations were measured in kidneys and liver; catalytic activity of glutathione peroxidase (GPx), superoxide dismutase (SOD), catalase (CAT) and glutathione (GSH) level in plasma, kidneys and liver, while malondialdehyde (MDA) concentration was measured in plasma, kidneys, liver and urine. Mycotoxin treatment significantly increased MDA concentration in plasma and kidney and decreased SOD activity in the liver. Rats treated with CTN and OTA125 + CTN had lower plasma GPx activity. Concentration of GSH in the kidney and protein carbonyls in the kidney and liver as well as GPx activity in the kidney and liver, SOD activity in the kidney and CAT activity in the liver were not affected. Protective effect of RSV was observed on GSH in the kidney and plasma and MDA in the kidney, plasma and urine. Oxidative stress is involved in OTA + CTN toxicity in vivo because such treatment affects parameters of oxidative stress, particularly in plasma. RSV can reduce but not overcome oxidative stress induced by combined OTA and CTN treatment.


Assuntos
Citrinina/toxicidade , Rim/efeitos dos fármacos , Fígado/efeitos dos fármacos , Ocratoxinas/toxicidade , Animais , Antioxidantes/farmacologia , Catalase/metabolismo , Glutationa/metabolismo , Glutationa Peroxidase/metabolismo , Rim/metabolismo , Fígado/metabolismo , Masculino , Malondialdeído/metabolismo , Estresse Oxidativo/efeitos dos fármacos , Ratos Wistar , Resveratrol/farmacologia , Superóxido Dismutase/metabolismo
2.
Eur Rev Med Pharmacol Sci ; 15(1): 71-8, 2011 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-21381501

RESUMO

OBJECTIVES: A balance between fibrinolysis and coagulation is crucial for maintaining haemostasis. A haemostatic disorder leads to various physiological changes and causes different diseases. Glycolipoprotein mixture (G-90), prepared from the tissue homogenate of the earthworm Eisenia foetida, was examined in vivo, in an animal study (conducted on Wistar rats) in order to determine its fibrinolytic and anticoagulation activity. MATERIALS AND METHODS: The influence of G-90 treatment on haematological and homeostatic parameters was monitored as well. RESULTS: Statistical analysis has shown the most pronounced effect of G-90 to be exerted on bleeding and coagulation times; the effects in reference were proven to be statistically significant (p = 0.03 and 0.005, respectively). A statistically significant effect of G-90 was also seen with thrombin time (p = 0.02) and plasminogen level (p = 0.004). CONCLUSION: The results have shown the influence of G-90 on blood coagulation to be very similar to that of heparin, a known anticoagulant. Thus G-90 could be considered as a new thrombolytic agent of use in veterinary and human medicine.


Assuntos
Anticoagulantes/farmacologia , Coagulação Sanguínea/efeitos dos fármacos , Fibrinolíticos/farmacologia , Glicoproteínas/farmacologia , Hemostasia/efeitos dos fármacos , Oligoquetos/química , Extratos de Tecidos/farmacologia , Animais , Heparina/farmacologia , Ratos , Ratos Wistar
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA